期刊文献+

CK19与胃肠胰神经内分泌肿瘤远处转移的相关性 被引量:1

Correlation between CK19 and of gastroenteropancreatic neuroendocrine neoplasms with distant metastasis
原文传递
导出
摘要 [目的]探讨CK19与胃肠胰神经内分泌肿瘤(GEP NEN)远处转移的相关性。[方法]对确诊的GEP NEN患者225例相关石蜡切片的核分裂计数、Ki-67(MIB-1)、CgA、Syn、CD56和CK19等指标的免疫组化再次染色评估;按照不同部位,进行CK19与病理参数(分级、淋巴结转移、远处转移)的相关性分析及单因素生存分析。[结果]与CK19阴性相比,胰腺部位CK19阳性表达患者提示较高的远处转移率(P=0.0241),及较高的分期(P=0.036),其他部位未提示病理参数相关。单因素生存分析显示:胰腺、直肠、胃部位CK19阳性表达患者与阴性表达患者未提示预后差异性(P值分别为0.609 7、0.831 3、0.838 5)。[结论]CK19阳性仅在胰腺神经内分泌肿瘤提示较高的远处转移率和ENETS分期,CK19阳性与GEP NEN患者预后未提示相关性。 [Objective]To investigate the correlation between CK19 and gastroenteropancreatic neuroen- docrine neoplasms(GEP NEN)with distant metastasis. [Methods]A retrospective study was carried out on 225 patients with GEP NEN who were diagnosed in our hospital between the year 2009:2015. IHC marker: Ki-67(MIB-1) ,CgA,CD56,Syn,CK19 were reviewed. According to different sites,the correlation between CK19 and pathological parameters(grading,lymph node metastasis,distant metastasis),and the correlation between CK19 and univariate survival analysis were studied. [Results]Patients with CK19 positive expres- sion in pancreas indicated higher distant metastasis rate(P= 0. 0241)and higher stage(P= 0. 036)compared with those CK19 negative. Univariate survival analysis showed that the CK19 positive expression in pancreas, rectum and stomach were not associated with poorer prognosis(P= 0. 6097,0. 8313,0. 8385). [Conclusion]CK19 positive indicates a higher rate of distant metastasis and a higher ENETS stage only in pancreatic neuroendocrine tumors,and CK19 positive is not associated with the prognosis of GEP NEN patients.
出处 《临床消化病杂志》 2016年第1期5-8,共4页 Chinese Journal of Clinical Gastroenterology
关键词 胃肠胰神经内分泌肿瘤 CK19 远处转移 gastroenteropancreatie neuroendocrine neoplasms CK19 distant metastasis
  • 相关文献

参考文献12

  • 1MAGGARD M A, O'CONNELL J B,KO C Y. Upda-ted population-based review of carcinoid tumors [J].Ann Surg, 2004,240 : 117 -122.
  • 2MODLIN I M,OBERG K,CHUNG D C,et al. Gastro-enteropancreatic neuroendocrine tumours [ J ]. LancetOncol,2008?9:61-72.
  • 3DESHPANDE V,FERNANDEZ-DEL CASTILLO C,MUZIKANSKY A,et al. Cytokeratin 19 is a powerfulpredictor of survival in pancreatic endocrine tumors[J]. Am J Surg Pathol,2004,28 :1145 - 1153.
  • 4ALI A’SERRA S, ASA S L,et al. The predictive valueof CK19 and CD99 in pancreatic endocrine tumors[J].Am J Surg Pathol,2006,30:1588-1594.
  • 5KORSE C M’TAAL B G, VINCENT A,et al. Choiceof tumour markers in patients with neuroendocrinetumours is dependent on the histological grade. Amarker study of Chromogranin A,neuron specific eno-lase,progastrin-releasing peptide and cytokeratin frag-ments[J]. Eur J Cancer,2012,48 :662 -671.
  • 6PIPER KUBRICK WOOD S,TURNPENNY LW,et al.Beta cell differentiation during early human pancreascievelopment[J]. J Endocrinol,2004,181:11 - 23.
  • 7ECCLES S A, WELCH D R. Metastasis : recent discov-eries and novel treatment strategies[J]. Lancet, 2007 ,369-1742-1757.
  • 8BARAK V’GOIKE H,PANARETAKIS K W,et al.Clinical utility of cytokeratins as tumor markers [J].Clin Biochem,2004 ?37 : 529 - 540.
  • 9CHETTY R’SERRA SJAIN R,et al. CK19 immuno-expression in extrapancreatic endocrine tumours of thegastrointestinal tract[J]. Histopathology, 2009 ?55 : 116-120.
  • 10SON E M,KIM J Y, AN S,et al. Clinical and prognos-tic significances of cytokeratin 19 and kit expression insurgically resectable pancreatic neuroendocrine tumors[J]. J Pathol Transl Med,2015 ?49 : 30 - 36.

同被引文献14

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部